M&G Investments

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

bit.bio announces £40m Series C from M&G Investments to pioneer human cell programming technology

10 Jan 2026

bit.bio announces £40m Series C from M&G Investments to pioneer human cell programming technology

bit.bio develops human cell programming technology that produces consistent, scalable human cells for research, drug discovery and toxicology, helping pharmaceutical and biotech companies reduce reliance on animal testing and improve predictive accuracy.

M&G Investments

- Life Sciences
1(12 months)
mandg.com/investments/gb
Update Information

More venture news

Cambridge Aerospace
10 Aug 2026
Cambridge Aerospace lands £222m Series C led by DFJ Growth for low-cost drone interceptor missiles
Series CDefence
Inforcer
30 Jul 2026
Inforcer raises £34m Series C from Insight Partners to expand Microsoft security and AI management platform for MSPs
Series CCybersecurity
Moa Technology
23 Jul 2026
Moa Technology unlocks £22m Series C led by Oxford Science Enterprises and Supernova to help farmers protect their harvests from crop-killing weeds
Series CAgriculture

M&G Investments

Investment Portfolio

bit.bio announces £40m Series C from M&G Investments to pioneer human cell programming technology

More venture news

Cambridge Aerospace lands £222m Series C led by DFJ Growth for low-cost drone interceptor missiles

Inforcer raises £34m Series C from Insight Partners to expand Microsoft security and AI management platform for MSPs

Moa Technology unlocks £22m Series C led by Oxford Science Enterprises and Supernova to help farmers protect their harvests from crop-killing weeds